The Riverside Company has generated a money multiple of 4.3x and a gross IRR of 60% on the sale of its Spanish pharmaceuticals business Euromed Botanicals to Frankfurt-listed Dermapharm Holding, Unquote understands.
GPs will sell their entire interest in the share capital of Altran for €14 per share
Vendors Zwanenberg and René Hochstenbach will retain minority stakes following the acquisition
Fund will target seed and series-A opportunities in technology sectors across Europe
Company plans to increase its revenues and to double its network of clinics by 2021